Atherosclerosis, inflammatory factor changes, cognitive disorder and vascular endothelial functions in patients with

Lirong Lin1, Yaxuan Zhang2, Qingxin Zeng1

  • 1Department of Neurology, Inner Mongolia Baogang Hospital, Baotou, Inner Mongolia, China.

Insights

Leukoaraiosis (LA) is linked to increased atherosclerosis, inflammation, and impaired cognitive and vascular functions. Higher LA grades correlate with worse outcomes, highlighting its systemic impact.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Geriatrics

Background:

  • Leukoaraiosis (LA) is a common finding in elderly individuals and patients with cerebrovascular disease.
  • LA is associated with an increased risk of cognitive impairment and stroke.
  • The underlying mechanisms linking LA to these outcomes are not fully understood.

Purpose of the Study:

  • To investigate the relationship between leukoaraiosis (LA) severity and atherosclerosis (AS).
  • To assess inflammatory factor levels, cognitive function, and vascular endothelial function in patients with varying grades of LA.
  • To explore the correlation between LA grades and cognitive disorders.

Main Methods:

  • 180 cerebral infarction patients were categorized into four LA grades.
  • Atherosclerosis was assessed using Doppler ultrasound and MRI.
  • Inflammatory markers (CRP, MMP-9), cognitive function (MMSE), and endothelial function (MDA, SOD, ET, NO) were measured.

Main Results:

  • AS incidence and inflammatory factor levels increased with LA grade.
  • Patients with higher LA grades showed lower MMSE scores and reduced SOD/NO levels.
  • Elevated MDA, ET, CRP, and MMP-9 were observed in more severe LA cases.

Conclusions:

  • Leukoaraiosis is associated with increased systemic inflammation.
  • LA is implicated in cognitive dysfunction and impaired vascular endothelial function.
  • These findings suggest LA as a potential marker for cerebrovascular disease progression.
Abstract

Related Concept Videos

Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.2K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
310
Cognitive Dissonance01:38

Cognitive Dissonance

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
36.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
343
Graded Potential01:19

Graded Potential

Graded potentials are localized fluctuations in the cell membrane's electrical charge, commonly found in the dendrites of neurons. The magnitude of these potential changes depends on the strength of the initiating stimulus. In a membrane at its resting potential, a graded potential signifies a voltage shift either above -70 mV or below -70 mV.
Graded potentials fall into two categories: depolarizing and hyperpolarizing. Depolarizing graded potentials typically occur when sodium (Na+) or...
6.9K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
976